Please login to the form below
National Cancer Institute
This page shows the latest National Cancer Institute news and features for those working in and with pharma, biotech and healthcare.
AZ’s comeback drug cediranib stumbles in phase 3 trial
The National Cancer Institute-sponsored GY004 study compared cediranib plus AZ and Merck &Co/MSD's leading PARP inhibitor Lynparza (olaparib) against chemo in patients with platinum-sensitive ovarian cancer, but ... and cervical cancer indications,
Latest news
-
Merck chases Roche with triple-negative breast cancer data for Keytruda
TNBC is an aggressive and hard-to-treat subtype of breast cancer, representing around 15% of all breast cancer worldwide, approximately 300, 000 cases every year. ... KEYNOTE-242 is a National Cancer Institute (NCI) sponsored trial testing adjuvant use
-
UPDATED: Senate officially confirms Stephen Hahn as FDA commissioner
Interim acting FDA commissioner Ned Sharpless returned to his role as the director of the National Cancer Institute, after completing his tenure at the federal agency on 1 November. ... This includes the Friends of Cancer research, as well as the
-
MD Anderson exec Stephen Hahn to be nominated FDA commissioner
Current acting FDA commissioner Ned Sharpless (pictured below, right) is set to return to his role as the director of the National Cancer Institute, after completing his tenure at the federal ... He oversaw the largest layoffs in its history but ensured
-
FDA will maintain the pace, vows Woodcock, but warns of skills gap
His successor, Ned Sharpless has been drafted in from his former role as head of the National Cancer Institute (NCI), but remains for now an interim Commissioner, and one certainly less
-
Iovance up on good ASCO abstract data for cervical cancer therapy
big gainer was Iovance Biotherapeutics which climbed on data for its cancer immunotherapies. ... Iovance’s approach to immunotherapy was pioneered by Steven Rosenberg of the US National Cancer Institute (NCI).
More from news
Approximately 1 fully matching, plus 88 partially matching documents found.
Latest Intelligence
-
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Selumetinib was given ‘breakthrough therapy’ status and rapidly green-lit by the FDA last month (April) following a promising National Cancer Institute (NCI) Cancer Therapy Evaluation Program sponsored phase 2 trial. ... I’ve been working on
-
20 for 2020 – Five pharma leaders to watch in 2020
and Braftovi) that Pfizer thinks could become a top industry franchise in colorectal cancer when combined with antibody drug cetuximab. ... as director of the National Cancer Institute.
-
30 Women Leaders in UK Healthcare (part 3)
As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of
-
An effective commercial model for cancer care
Treatments for cancer are among the most expensive of all, regardless of disease. ... In an online survey of 8, 411 cancer patients administered by LIVESTRONG (the Lance Armstrong Foundation) and the National Cancer Institute's Health Information
-
EATRIS and the new age of partnering
In a display of its global ambition, EATRIS is joining with Cancer Research UK to bring representatives of the US's National Cancer Institute to a workshop in Brussels in October ... In October the National Cancer Institute will meet with specialists -
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
McCann Health France strengthens team with two new hires
Prior to McCann Health France, she served as scientific director at various international health organisations, including the ARC Foundation for Cancer Research and the French National Cancer Institute.
-
Cancer Research UK's Karen Vousden to join BMS board
She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National ... Cancer Institute.
-
AZ and Medimmune bolsters immuno-oncology leadership
roles at the National Cancer Institute (NCI). ... Institut Gustave Roussy - a leading cancer-research institute.
-
Iris Pauporté joins OSE Immunotherapeutics
Pauporté will lead the clinical development of the firm's lung cancer candidate Tedopi, which is currently in phase III trials, and will be responsible for exploring the drug's potential ... She brings over 20 years of biomedical and clinical research
-
AstraZeneca appoints Sean Bohen as chief medical officer
Before joining Genentech he was a clinical instructor in oncology at Stanford University School of Medicine, a research associate at the Howard Hughes Medical Institute and a postdoctoral fellow at the ... National Cancer Institute.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
September 2020: diversity and inclusion in clinical trials round-up
population. There is the same problem in Europe.” Luis E. Raez, MD, of Memorial Cancer Institute/Florida International University in Miami, one of the co-authors. ... According to data from the National Cancer Institute, cancer death rates have been
-
Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)
References. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Cancer stat facts: Liver and intrahepatic bile duct cancer. ... 2018; 15(10):599-616. National Cancer Institute. Surveillance, Epidemiology, and End Results
-
World AIDS Day 2018: Fighting the stigma surrounding HIV
HIV infection. Nat Rev Dis Primers. 2015; 1: 15035. National Cancer Institute. ... HIV infection and cancer risk. Available at: . Accessed November 2018. UCSF Health. AIDS diagnosis. Available at: . Accessed November 2018. Avert. Symptoms and stages of
-
Mastering the precision medicine opportunity
The National Cancer Institute and the Centre for Disease Control both use the 4Ps model to define precision medicine, considering it a form of evidence-based medicine that is:. ... Parallel to the increasing number of testing options is the evolving
-
ASCO 2015: What you missed in Chicago
Specifically, we thought the checkpoint inhibitors in head and neck, lung cancer and melanoma really shone. ... The second area that really impressed me was the large National Cancer Institute (NCI) trial[3] that will look to treat patients with solid
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Medical Editor
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- Nucleus Global announces a trio of promotions
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer introduces new logo in a ‘shift from commerce to science’
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
90TEN
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
